We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+5.12%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.78B
AUM Growth
+$56.1M
Cap. Flow
-$188M
Cap. Flow %
-3.26%
Top 10 Hldgs %
16.17%
Holding
795
New
72
Increased
310
Reduced
286
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$28.5M
2
META icon
Meta Platforms (Facebook)
META
+$26M
3
TRV icon
Travelers Companies
TRV
+$17.1M
4
LUV icon
Southwest Airlines
LUV
+$16.6M
5
CI icon
Cigna
CI
+$16.6M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$76.5M
2
JNJ icon
Johnson & Johnson
JNJ
+$27.8M
3
GILD icon
Gilead Sciences
GILD
+$26.5M
4
CPB icon
Campbell Soup
CPB
+$20.6M
5
AMZN icon
Amazon
AMZN
+$20.2M

Sector Composition

Rank Sector Weight
1 Healthcare 22.62%
2 Technology 14.65%
3 Financials 14.55%
4 Consumer Discretionary 9.89%
5 Communication Services 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WY icon
426
Weyerhaeuser
WY
$17.3B
$2.11M 0.04%
59,814
+6,523
+12% +$231K
MGI
427
DELISTED
MoneyGram International, Inc. New
MGI
$2.11M 0.04%
160,000
-143,066
-47% -$2.09M
TXNM
428
TXNM Energy Inc
TXNM
$6.47B
$2.08M 0.04%
51,368
-41,993
-45% -$1.8M
TSM icon
429
TSMC
TSM
$2.09T
$2.07M 0.04%
52,050
-1,952
-4% -$79.1K
LEG icon
430
Leggett & Platt
LEG
$1.52B
$2.07M 0.04%
43,283
– –
CPB icon
431
Campbell Soup
CPB
$6.51B
$2.06M 0.04%
42,757
-433,628
-91% -$20.6M
COL
432
DELISTED
Rockwell Collins
COL
$2.05M 0.04%
15,096
+1,915
+15% +$257K
SYRS
433
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.04M 0.04%
21,000
+9,000
+75% +$1.21M
PBA icon
434
Pembina Pipeline
PBA
$29.9B
$2.04M 0.04%
56,059
+6,185
+12% +$214K
EQR icon
435
Equity Residential
EQR
$25.4B
$2.03M 0.04%
31,843
+1,869
+6% +$125K
BIO icon
436
Bio-Rad Laboratories Class A
BIO
$8.42B
$2.03M 0.04%
+8,500
New +$2.06M
KR icon
437
Kroger
KR
$34.8B
$2.02M 0.03%
73,388
+6,147
+9% +$143K
MSI icon
438
Motorola Solutions
MSI
$69.4B
$2.01M 0.03%
22,225
-5,863
-21% -$534K
IQV icon
439
IQVIA
IQV
$34.7B
$2M 0.03%
20,464
-1,843
-8% -$188K
TU icon
440
Telus
TU
$16B
$2M 0.03%
104,996
-8,396
-7% -$155K
AKCA
441
DELISTED
Akcea Therapeutics Inc
AKCA
$1.99M 0.03%
114,571
-77,487
-40% -$1.52M
DG icon
442
Dollar General
DG
$25.9B
$1.98M 0.03%
21,298
+1,985
+10% +$171K
ARDX icon
443
Ardelyx
ARDX
$1.24B
$1.98M 0.03%
+300,000
New +$1.78M
SRE icon
444
Sempra
SRE
$60.8B
$1.97M 0.03%
36,932
+1,682
+5% +$97.5K
BXP icon
445
Boston Properties
BXP
$11B
$1.95M 0.03%
14,970
+492
+3% +$61.7K
DOV icon
446
Dover
DOV
$27.2B
$1.94M 0.03%
23,799
+5,285
+29% +$409K
RHT
447
DELISTED
Red Hat Inc
RHT
$1.93M 0.03%
16,056
+1,435
+10% +$176K
DLTR icon
448
Dollar Tree
DLTR
$23.1B
$1.92M 0.03%
17,866
-44,973
-72% -$4.4M
L icon
449
Loews
L
$24.3B
$1.92M 0.03%
38,272
– –
PXD
450
DELISTED
Pioneer Natural Resource Co.
PXD
$1.91M 0.03%
11,043
-1,510
-12% -$233K
16 17
18
19 20

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2017 Portfolio in Review

As of Q4 2017, Candriam SCA held 795 positions worth $5.78B, up 0.98% from $5.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA withdrew a net $188M in Q4 2017, closing 45 positions and reducing 286 holdings. Its most notable exit was Hubbell, an estimated $11.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Candriam SCA opened a new position in 58.com Inc worth $15.6M.

  • Candriam SCA's largest Q4 2017 buy was 58.com Inc: 218,000 shares worth $15.6M.
  • Candriam SCA added most to Amgen in Q4 2017, an estimated $28.5M increase.
  • Candriam SCA's biggest Q4 2017 reduction was Biogen, cutting an estimated $76.5M.
  • Candriam SCA fully exited Hubbell in Q4 2017, selling an estimated $11.1M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.78B portfolio in Q4 2017.
  • Candriam SCA opened 72 new positions and closed 45 in Q4 2017.
  • Candriam SCA's portfolio value rose 0.98% quarter-over-quarter to $5.78B.

Based on Candriam SCA's 13F filing for Q4 2017, filed 7 Feb 2018.